Results 131 to 140 of about 295,040 (235)
Background: Treatment of patients with thyroid cancer with Na[131I]I is routinely performed with empirical activity levels. Treatment success may be expected to correlate with the absorbed doses delivered to targets (thyroid remnants or metastatic ...
Flux, GD +5 more
core
FAM19A5 is an independent prognostic biomarker in thyroid cancer. [PDF]
Luan S, Yuan H, Liu D.
europepmc +1 more source
Impact of health information prescription in thyroid cancer. [PDF]
Bianchini M +7 more
europepmc +1 more source
Development of Graves orbitopathy after thyroidectomy for thyroid cancer. [PDF]
Hormiz M +5 more
europepmc +1 more source
Role of the ETV5/p38 Signaling Axis in Aggressive Thyroid Cancer Cells. [PDF]
Houl JH +22 more
europepmc +1 more source
Immunotherapy in Thyroid Cancer: Current Strategies and Challenges. [PDF]
Zhang Q +5 more
europepmc +1 more source
Lipid Metabolism-Related Genes Define Prognosis and Therapeutic Targets in Thyroid Cancer. [PDF]
Wang T, Nan B, Sa Q, Xu N, Zhang W.
europepmc +1 more source
Acetate Metabolism in Thyroid Cancer Progression. [PDF]
Baldini E +9 more
europepmc +1 more source
Anaplastic thyroid cancer: Cases, incidence, prevalence and survival in Germany. [PDF]
Singer S +8 more
europepmc +1 more source

